SMTL ID : 6te6.2 (1 other biounit)

Crystal structure of Dot1L in complex with an inhibitor (compound 3).

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

monomer

Ligands

1 x N4W: ~{N}1-[(~{S})-(3-chlorophenyl)-pyridin-2-yl-methyl]-4-methylsulfonyl-~{N}2-pyrimidin-2-yl-benzene-1,2-diamine(Non-covalent)

N4W.1: 18 residues within 4Å: Chain A: P.131, F.132, Y.137, S.141, L.144, V.145, M.148, V.170, F.240, V.241, N.242, F.244, V.268, S.269, S.270, V.311, S.312, Y.313 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:F.132, A:Y.137, A:L.144, A:V.145, A:V.170, A:N.242, A:F.244 Hydrogen bonds: A:N.242, A:N.242, A:N.242, A:S.270 pi-Stacking: A:F.132, A:F.240, A:F.240, A:F.244

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stauffer, F. et al., New Potent DOT1L Inhibitors forin VivoEvaluation in Mouse. Acs Med.Chem.Lett. (2019)

Release Date

2019-12-11

Peptides

Histone-lysine N-methyltransferase, H3 lysine-79 specific: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Histone-lysine N-methyltransferase, H3 lysine-79 specific

Related Entries With Identical Sequence